
New Drug Combo Offers Hope for Untreatable Colon Cancer
Patients in a Phase 3 clinical trial who received sotorasib and panitumumab lived longer, suggesting the combination therapy could become the new standard of care. A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic …